Long-term Effects of Budesonide/Formoterol Pressurized Metered-Dose Inhaler on Chronic Obstructive Pulmonary Disease (COPD) Symptoms and Health Status in Patients With COPD

Health Status ◽

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Long Term Effects ◽

Metered Dose

LONG-TERM EFFICACY OF BUDESONIDE/FORMOTEROL ADMINISTERED VIA ONE PRESSURIZED METERED-DOSE INHALER IN PATIENTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEST Journal ◽

10.1378/chest.134.4_meetingabstracts.p103001 ◽

2008 ◽

Vol 134 (4) ◽

pp. 103P ◽

Cited By ~ 1

Author(s):

Stephen I. Rennard ◽

Donald P. Tashkin ◽

Jennifer McElhattan ◽

Mitchell Goldman ◽

Philip E. Silkoff

Keyword(s):

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Term Efficacy ◽

Metered Dose ◽

LONG-TERM TOLERABILITY OF BUDESONIDE AND FORMOTEROL ADMINISTERED IN ONE PRESSURIZED METERED-DOSE INHALER IN PATIENTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEST Journal ◽

10.1378/chest.134.4_meetingabstracts.p103003 ◽

2008 ◽

Vol 134 (4) ◽

pp. 103P ◽

Cited By ~ 1

Author(s):

Stephen I. Rennard ◽

Donald P. Tashkin ◽

Jennifer McElhattan ◽

Mitchell Goldman ◽

Philip E. Silkoff

Keyword(s):

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Term Tolerability ◽

Long-Term Tolerability Of Budesonide/Formoterol Pressurized Metered-Dose Inhaler In Patients With Chronic Obstructive Pulmonary Disease And A History Of Exacerbations

10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1597 ◽

2011 ◽

Cited By ~ 1

Author(s):

John G. Southard ◽

Amir Sharafkhaneh ◽

Mitchell Goldman ◽

Tom Uryniak ◽

Ubaldo J. Martin

Keyword(s):

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Metered Dose ◽

History Of ◽

Term Tolerability

Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease

Respiratory Medicine ◽

10.1016/j.rmed.2017.03.015 ◽

2017 ◽

Vol 126 ◽

pp. 105-115 ◽

Cited By ~ 40

Author(s):

Nicola A. Hanania ◽

Donald P. Tashkin ◽

Edward M. Kerwin ◽

James F. Donohue ◽

Michael Denenberg ◽

...

Keyword(s):

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Safety And Efficacy ◽

Metered Dose ◽

Delivery Technology

Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in chronic obstructive pulmonary disease

Drugs & Therapy Perspectives ◽

10.2165/11204250-000000000-00000 ◽

2010 ◽

Vol 26 (11) ◽

pp. 6-9

Author(s):

&NA;

Keyword(s):

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Effects of Glycopyrronium Bromide (GB) Delivered Via a Pressurized Metered-Dose Inhaler (pMDI) in Subjects with Chronic Obstructive Pulmonary Disease (COPD) on Cardiovascular Parameters: Results from the GLIMMER Study

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7371 ◽

2019 ◽

Author(s):

E.M. Kerwin ◽

G. Feldman ◽

C. Beaudot ◽

G. Georges

Keyword(s):

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Cardiovascular Parameters ◽

Glycopyrronium Bromide ◽

Metered Dose ◽

EFFECT OF PATIENT SEX ON FORCED EXPIRATORY VOLUME IN 1 SECOND IN PATIENTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE RECEIVING BUDESONIDE/FORMOTEROL PRESSURIZED METERED-DOSE INHALER

CHEST Journal ◽

10.1378/chest.136.4_meetingabstracts.94s-b ◽

2009 ◽

Vol 136 (4) ◽

pp. 94S

Author(s):

Sheila Weaver ◽

Stephen I. Rennard ◽

Donald P. Tashkin ◽

Jennifer McElhattan ◽

Ubaldo J. Martin

Keyword(s):

Pulmonary Disease ◽

Forced Expiratory Volume ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

BMC Pulmonary Medicine ◽

10.1186/1471-2466-14-118 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 14

Author(s):

Stephen Rennard ◽

Charles Fogarty ◽

Colin Reisner ◽

Carlos Fernandez ◽

Tracy Fischer ◽

...

Keyword(s):

Pulmonary Disease ◽

Randomized Study ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Metered Dose

EFFECT OF BUDESONIDE/FORMOTEROL PRESSURIZED METERED-DOSE INHALER BY AGE GROUP ON FORCED EXPIRATORY VOLUME IN 1 SECOND IN PATIENTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEST Journal ◽

10.1378/chest.136.4_meetingabstracts.95s ◽

2009 ◽

Vol 136 (4) ◽

pp. 95S

Author(s):

Stephen I. Rennard ◽

Donald P. Tashkin ◽

Jennifer McElhattan ◽

Ubaldo J. Martin

Keyword(s):

Pulmonary Disease ◽

Forced Expiratory Volume ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Age Group ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease by Baseline CAT Score: Post-Hoc Analysis of the ETHOS Study

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2246 ◽

2021 ◽

Author(s):

J. Hurst ◽

F.J. Martinez ◽

D. Singh ◽

P. Darken ◽

M. Patel ◽

...

Keyword(s):

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Post Hoc Analysis ◽

Metered Dose ◽

Post Hoc ◽

Formoterol Fumarate